RESPONSE GENETICS, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
WHEREAS, the Company desires to grant to the Participant an Option to purchase shares of its common stock, $.01 par value per share (the “Shares”), under and for the purposes set forth in the Company’s 2006 Employee, Director and Consultant Stock Plan (the “Plan”);
INCENTIVE STOCK OPTION AGREEMENT RESPONSE GENETICS, INC.Incentive Stock Option Agreement • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
AGREEMENT made as of the ___ day of _______ 200_, between Response Genetics, Inc. (the “Company”), a Delaware corporation and ____________, an employee of the Company (the “Employee”).
ContractUnderwriters’ Warrant • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • New Jersey
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
Shares of Common Stock RESPONSE GENETICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • New York
The undersigned hereby further agrees that, without the prior written consent of the Representative, which consent shall not be unreasonably withheld, during the Lock-Up Period the undersigned will not: (x) file or participate in the filing with the Securities and Exchange Commission of any registration statement, or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document with respect to any proposed offering or sale of a Relevant Security and (y) exercise any rights the undersigned may have to require registration with the Securities and Exchange Commission of any proposed offering or sale of a Relevant Security.
AGREEMENT OF COLLABORATIONAgreement of Collaboration • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances
WHEREAS, RGI is engaged in the business of providing pharmaceuticals and biotechnology companies with pharmacogenomic analysis services; and
